Endothelin antagonist improves viability of liver grafts from non-heart-beating donors

scientific article published on 01 February 1999

Endothelin antagonist improves viability of liver grafts from non-heart-beating donors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0041-1345(98)01708-4
P698PubMed publication ID10083190

P2093author name stringK Fukunaga
M Otsuka
K Fukao
H Taniguchi
Y Takada
P2860cites workPharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in ratsQ28368149
A novel potent vasoconstrictor peptide produced by vascular endothelial cellsQ29620540
Relationship between early liver graft viability and enzyme activities in effluent preservation solutionQ71770342
Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in ratsQ72054035
Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbancesQ72271861
Cyclic hexapeptide endothelin receptor antagonists highly potent for both receptor subtypes ETA and ETBQ72425546
Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liverQ73208997
P433issue1-2
P407language of work or nameEnglishQ1860
P304page(s)460-461
P577publication date1999-02-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleEndothelin antagonist improves viability of liver grafts from non-heart-beating donors
P478volume31